Glaukos Announces Participation in Upcoming Investor Conferences

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the following upcoming investor conferences: Piper Sandler Annual Healthcare Conference (a pre-recorded fireside chat presentation will be available for viewing beginning on Monday, November